Open access
Aug 2026
In vitro antiviral effects of an mTORC1 inhibitor targeting the rapamycin-binding protein complex.
WRX606 is evaluated, a novel mTORC1 inhibitor, as a broad-spectrum antiviral candidate against representative RNA viruses and offers a potential host-directed strategy for addressing viral infections.
Takafumi Yamada, R. Matsuura, S. Watanuki et al.
· Microbial Pathogenesis · 0 citations